Risk of IOP Increase Associated With Intravitreal Injections of VEGF Inhibitors in Patients Without Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study
Am J Ophthalmol 2022 Nov 18;[EPub Ahead of Print], A Spini, S Giometto, S Donnini, M Posarelli, F Dotta, M Ziche, GM Tosi, A Girardi, E Lucenteforte, R Gini, M Etminan, G VirgiliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.